LifeStance Health Group, Inc. (LFST) EBITDA
- 2026-06-30: Basis Reported; EBITDA $41.96M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA $32.65M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA $28.43M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA $17.75M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | $41.96M | (m) | (m) | (m) | 9.64% | $11.99M* | $99.91M* | (m) | (m) | $108.14M | $3.85M |
|---|
| 2026-03-31 | Reported | $32.65M | (m) | (m) | (m) | 8.09% | $10.77M | $33.11M | (m) | (m) | $100.33M | $5.52M |
|---|
| 2025-12-31 | Reported | $28.43M | (m) | (m) | (m) | 7.44% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | $17.75M | (m) | (m) | (m) | 4.88% | $10.29M* | $27.29M* | (m) | (m) | $95.61M | $3.50M |
|---|
| 2025-06-30 | Reported | $7.69M | (m) | (m) | (m) | 2.23% | $7.75M* | $64.40M* | (m) | (m) | $97.38M | -$2.15M |
|---|
| 2025-03-31 | Reported | $11.89M | (m) | (m) | (m) | 3.57% | $7.17M | -$3.09M | (m) | (m) | $94.43M | -$2.18M |
|---|
| 2024-12-31 | Reported | $11.18M | (m) | (m) | (m) | 3.43% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | $10.46M | (m) | (m) | (m) | 3.34% | $5.05M* | $22.72M* | (m) | (m) | $85.27M | $575.00K |
|---|
| 2024-06-30 | Reported | -$5.82M | (m) | (m) | (m) | -1.86% | $5.11M* | $44.06M* | (m) | (m) | $95.15M | $656.00K |
|---|
| 2024-03-31 | Reported | -$6.75M | (m) | (m) | (m) | -2.25% | $5.10M | -$21.84M | (m) | (m) | $88.93M | $363.00K |
|---|
| 2023-12-31 | Reported | -$22.6M | (m) | (m) | (m) | -8.05% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$64.91M | (m) | (m) | (m) | -24.69% | $9.80M* | -$25.36M* | (m) | (m) | $130.94M | -$16.39M |
|---|
| 2023-06-30 | Reported | -$39.06M | (m) | (m) | (m) | -15.05% | $11.58M* | -$434.00K* | (m) | (m) | $101.85M | -$6.54M |
|---|
| 2023-03-31 | Reported | -$25.2M | (m) | (m) | (m) | -9.98% | $7.73M | -$7.89M | (m) | (m) | $84.63M | -$4.04M |
|---|
| 2022-12-31 | Reported | -$37.25M | (m) | (m) | (m) | -16.24% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$31.16M | (m) | (m) | (m) | -14.32% | $15.10M* | $5.73M* | (m) | (m) | $81.25M | -$4.35M |
|---|
| 2022-06-30 | Reported | -$53.72M | (m) | (m) | (m) | -25.64% | $25.86M* | $7.83M* | (m) | (m) | $103.56M | $923.00K |
|---|
| 2022-03-31 | Reported | -$59.12M | (m) | (m) | (m) | -29.11% | $27.91M | $3.31M | (m) | (m) | $103.37M | -$6.68M |
|---|
| 2021-12-31 | Reported | -$108.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$120.7M | (m) | (m) | (m) | -69.44% | $24.01M* | -$14.21M* | (m) | (m) | $162.94M | -$8.75M |
|---|
| 2021-06-30 | Reported | -$43.98M | (m) | (m) | (m) | -3242.99% | $20.72M* | -$16.91M* | (m) | (m) | $85.48M | -$3.79M |
|---|
| 2021-03-31 | Reported | $1.73M | (m) | (m) | (m) | 1.21% | $11.08M | $9.91M | (m) | (m) | $32.65M | -$2.76M |
|---|
| 2020-09-30 | Reported | $4.34M | (m) | (m) | (m) | 9865.91% | $9.53M* | $11.19M* | (m) | (m) | $19.53M | -$1.07M |
|---|
| 2020-06-30 | Reported | $867,000.00 | (m) | (m) | (m) | 5418.75% | $5.12M | -$37.32M | (m) | (m) | $8.64M | $1.37M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $65.77M | (m) | (m) | (m) | 4.62% | $36.13M | $146.15M | (m) | (m) | $382.20M | $2.70M |
|---|
| 2024-12-31 | Reported | $9.06M | (m) | (m) | (m) | 0.72% | $21.57M | $107.26M | (m) | (m) | $363.06M | -$170.00K |
|---|
| 2023-12-31 | Reported | -$151.76M | (m) | (m) | (m) | -14.38% | $40.52M | -$16.88M | (m) | (m) | $410.79M | -$20.32M |
|---|
| 2022-12-31 | Reported | -$181.26M | (m) | (m) | (m) | -21.09% | $79.25M | $52.79M | (m) | (m) | $377.99M | -$17.17M |
|---|
| 2021-12-31 | Reported | -$271.26M | (m) | (m) | (m) | -18772.25% | $94.49M | $9.42M | (m) | (m) | $433.73M | -$25.91M |
|---|
| 2019-12-31 | Reported | $18.28M | (m) | (m) | (m) | 8.60% | $14.31M | $17.05M | (m) | (m) | $41.06M | $2.21M |
|---|